Post-IPO Equity - Alnylam Pharmaceuticals - Apr 8, 2019 Funding Round Profile - Cointime

Bitcoin $87,244.30 -1.53%
Ethereum $3,170.67 -4.99%
BNB $607.86 -7.15%
Optimism $1.55 -13.25%
Arbitrum $0.59 -10.88%
Solana $206.60 -5.65%
Polygon $0.37 -10.81%
Cosmos $5.00 -9.10%
Avalanche $32.25 -8.18%

Bitcoin $87,244.30 -1.53%
Ethereum $3,170.67 -4.99%
BNB $607.86 -7.15%
Optimism $1.55 -13.25%
Arbitrum $0.59 -10.88%
Solana $206.60 -5.65%
Polygon $0.37 -10.81%
Cosmos $5.00 -9.10%
Avalanche $32.25 -8.18%

Alnylam Pharmaceuticals

company

Funding Round

Post-IPO Equity

Money Raised

$ 800M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Regeneron	-	Yes	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Jul 7, 2003	Private Equity（PE）	$ 24.60M	Merck,ARCH Venture Partners	Detail
Mar 28, 2011	Post-IPO Equity	$ 10M	Takeda	Detail